Kiora Pharmaceuticals Inc SEC filings KPRX

Kiora Pharmaceuticals Inc has 926 filings in SEC EDGAR's recent list, going back to Aug 9, 2006. Its latest annual report, Form ARS, was filed on May 1, 2026 for the period ended Dec 31, 2025. The latest quarterly report (Form 10-Q) was filed on Aug 7, 2026, covering the quarter ended Jun 30, 2026. The most recent current report (Form 8-K) was filed on Oct 29, 2026 (material agreement, regulation fd disclosure). The company's fiscal year ends on December 31.

Form Description Filed Period
ARS Annual report to shareholders May 1, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2026 Dec 31, 2025
10-K Annual report Mar 25, 2025 Dec 31, 2024
10-K Annual report Mar 25, 2024 Dec 31, 2023
10-K Annual report Mar 23, 2023 Dec 31, 2022
10-K/A Amended annual report Jul 7, 2022 Dec 31, 2021
10-K Annual report Apr 15, 2022 Dec 31, 2021
10-K Annual report Mar 25, 2021 Dec 31, 2020
10-K Annual report Mar 4, 2020 Dec 31, 2019
10-K Annual report Mar 1, 2019 Dec 31, 2018
10-K Annual report Mar 2, 2018 Dec 31, 2017
10-K Annual report Feb 23, 2017 Dec 31, 2016
10-K Annual report Mar 30, 2016 Dec 31, 2015
10-K Annual report Mar 31, 2015 Dec 31, 2014

Showing 14 filings. Main filings leave out insider and ownership forms such as Form 4; choose a type above to see them. Each form opens on SEC.gov. Older filings are on SEC EDGAR.

New to this? Read What Are SEC Filings? 10-K, 10-Q, 8-K and Other Forms Explained.

Company profile

Industry
Pharmaceutical Preparations (SIC 2834)
Listed as
KPRX (Nasdaq), KPHMW (OTC)
Fiscal year ends
December 31
Incorporated in
DE
Headquarters
Encinitas, CA
SEC filer status
Non-accelerated filer, Smaller reporting company
SEC CIK
1372514
Former names
EYEGATE PHARMACEUTICALS INC (until Nov 4, 2021)

Other Pharmaceutical Preparations companies

All 570 Pharmaceutical Preparations companies

Source: SEC EDGAR filings. This is company-reported data, not investment advice.